Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea · Delayed Price · Currency is KRW 82,800
+200 (0.24%)
Last updated: Oct 28, 2025, 2:22 PM KST
KRX:185750 Market Cap
KRX:185750 has a market cap or net worth of 1.09 trillion as of October 28, 2025. Its market cap has decreased by -26.03% in one year.
Market Cap
1.09T
Enterprise Value
1.08T
Revenue
1.66T
Ranking
n/a
PE Ratio
17.87
Stock Price
82,800.00
Market Cap Chart
Since December 6, 2013, KRX:185750's market cap has increased from 677.45B to 1.09T, an increase of 60.65%. That is a compound annual growth rate of 4.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 1.10T | -6.91% |
| Dec 30, 2024 | 1.18T | -29.22% |
| Dec 28, 2023 | 1.67T | 66.27% |
| Dec 29, 2022 | 1.00T | -23.66% |
| Dec 30, 2021 | 1.31T | -49.00% |
| Dec 30, 2020 | 2.57T | 145.08% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 83.84T |
| Celltrion | 38.09T |
| ALTEOGEN | 23.85T |
| Yuhan | 8.54T |
| SK Biopharmaceuticals | 8.34T |
| Peptron | 6.00T |
| HLB Co., Ltd. | 5.98T |
| PharmaResearch | 5.69T |